Moderator:
Jason Saliba, PhD
Senior Scientist
Washington University, St. Louis, MO
Presenter(s):

Dr. Aaron Mansfield, MD
Medical Oncologist, Co-Director of Precision Cancer Therapeutics for the Center of Individualized Medicine
Dr. Mansfield is a medical oncologist at Mayo Clinic with a focus on thoracic malignancies and early therapeutics. He is co-director of the Precision Cancer Therapeutics group within the Center for Individualized Medicine. He has played a significant role in clinical trials leading to FDA approval of agents for thoracic malignancies including atezolizumab for small cell lung cancer, pralsetinib for RET-fusion non-small cell lung cancer and the combination of ipilimumab with nivolumab for mesothelioma. His laboratory runs many translational projects to discover and validate biomarkers in thoracic malignancies.

Dr. Kevin Halling, MD, PhD
Molecular Pathologist, Laboratory Director, and Professor in the Division of Laboratory Genetics and Genomics, Mayo Clinic Rochester, MN
Dr. Halling is a molecular pathologist and a Professor in the Division of Laboratory Genetics and Genomics at Mayo Clinic in Rochester, MN. He received his M.D. and Ph.D. from the University of Kansas and completed an Anatomic and Clinical pathology residency and Clinical Molecular Genetics fellowship at the Mayo Clinic. His primary area of interest is in the development and implementation of molecular diagnostic tests that can be used for the diagnosis and treatment of cancer (solid tumor) patients. Dr. Halling has published over 150 papers that mostly relate to genetic testing of cancer.

Beth Pitel, MS
Senior Developer, Assistant Professor in the Division of Laboratory Genetics and Genomics, Office of Translational Research, Innovation, and Test Development, Mayo Clinic, Rochester, MN
Beth is a Senior Developer involved with the development and maintenance of several testing modalities, including NGS oncology panels, RNAseq, mate pair sequencing, chromosomal microarray, and qPCR. She leads the Genomics of Oncology Annotation Team (GOAT), a group that creates interpretive resources for the laboratory based on current knowledge in the field of cancer genetics. Beth has worked at Mayo Clinic since 2007 and completed her Master’s degree from the Mayo Graduate School in Biochemistry and Molecular biology in 2015 with foci on cancer biology and bioinformatics. She co-leads the VICC VMTB and is an active member of ClinGen Somatic working group and the Cancer Genomics Consortium. Beth has co-authored over 30 peer-reviewed manuscripts focusing mainly on cancer genetic alterations and methodologies.
Planning Committee:
Beth Pitel, MS, CG(ASCP)
Gordana Raca, MD, PhD, FACMG
Manuela Benary, PhD
Jason Saliba, PhD
Jane Radford, MHA, CHCP